Genital vitiligo-like depigmentation following use of imiquimod 5% cream.
Serrão
Vasco Vieira
VV
Páris
Filipa Rocha
FR
Feio
Ana Barata
AB
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000287:Administration, Topical; D000328:Adult; D000634:Aminoquinolines / Q000009:adverse effects*; D003218:Condylomata Acuminata / Q000188:drug therapy; D006801:Humans; D000077271:Imiquimod; D008297:Male; D010409:Penile Diseases / Q000139:chemically induced* / Q000473:pathology; D010413:Penis / Q000473:pathology; D012867:Skin / Q000473:pathology; D014820:Vitiligo / Q000139:chemically induced* / Q000473:pathology
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod